切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2017, Vol. 07 ›› Issue (01) : 32 -35. doi: 10.3877/cma.j.issn.2095-123X.2017.01.008

所属专题: 文献

综述

Humanin及其衍生物与认知障碍
张馨娜1, 王涛1, 李洪军1, 孙宝民2, 张新萍1,()   
  1. 1. 271000 山东泰安,泰安市中心医院神经内科
    2. 271000 山东泰安,泰安市中心医院临床心理科
  • 收稿日期:2016-08-08 出版日期:2017-02-01
  • 通信作者: 张新萍
  • 基金资助:
    山东省医药卫生科技发展计划项目(2015WS0119)

Humanin and its derivatives with cognitive impairment

Xinna Zhang1, Tao Wang1, Hongjun Li1, Baomin Sun2, Xinping Zhang1,()   

  1. 1. Department of Neurology, Taian City Central Hospital, Taian 271000, Shandong, China
    2. Department of Clinical Psychology, Taian City Central Hospital, Taian 271000, Shandong, China
  • Received:2016-08-08 Published:2017-02-01
  • Corresponding author: Xinping Zhang
  • About author:
    Corresponding author: Zhang Xinping, Email:
引用本文:

张馨娜, 王涛, 李洪军, 孙宝民, 张新萍. Humanin及其衍生物与认知障碍[J]. 中华脑科疾病与康复杂志(电子版), 2017, 07(01): 32-35.

Xinna Zhang, Tao Wang, Hongjun Li, Baomin Sun, Xinping Zhang. Humanin and its derivatives with cognitive impairment[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2017, 07(01): 32-35.

阿尔茨海默病(Alzheimer disease,AD)和血管性痴呆(Vascular dementia,VD)是临床最常见的老年痴呆类型,但因缺乏有效的治疗措施而成为严重威胁老年人身心健康和生存质量的主要疾病之一。近来研究表明,Humanin(HN)具有广泛的神经保护作用,除能拮抗β淀粉样蛋白(amyloid beta, Aβ)引起神经细胞损伤外,还能保护缺血引起的PC12细胞的损伤,为开发特异性防治痴呆的新药物带来希望。本文就HN与AD、VD之间的研究进展做一综述。

Alzheimer disease and vascular dementia, known as the most common clinical types of dementia, have became one of the major disease that seriously threaten the physical and mental health and living quality of old people, because of the lack of effective treatment measures. Recent studies have shown that humanin has extensive nerve protective effect, such as lessening injury of PC12 cells caused by ischemia; besides restraining neuron damage caused by amyloid beta. Thus, humanin might bring hope to the development of specific new drugs for the prevention and control of dementia. In this paper, we review the advances in the research between humanin, Alzheimer disease and vascular dementia.

[1]
Hashinmoto Y,Ito Y,Niikura T, et al. Mechanisms of neuroprotection by a novel factor humanin from Swedish mutant amyloid precursor protein[J]. Biochem Biophys Res Commun, 2001, 283(2):460-468.
[2]
Sponne I,Fifre A,Koziel V, et al. Humanin rescues cortical neurons from prion-peptide-induced apoptosis[J]. Mol Cell Neurosci, 2004, 25(1):95-102.
[3]
Tsukamoto E,Hashimoto Y,Kanekura K, et al. Characterization of the toxic mechanism triggered by Alzheime's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells [J]. J Neurosci Res, 2003, 73(5):627-636.
[4]
Niikura T,Sidahmed E,Hirata-Fukae C, et al. A humanin derivative reduces amyloid Beta accumulation and ameliorates memory deficit in triple transgenic mice [J]. PLoS One, 2011, 6(1):e16259.
[5]
Zhang W,Zhang W,Li Z, et al. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice[J]. Pharmacol Biochem Behav, 2012, 100(3):361-369.
[6]
Matsuoka M,Hashimoto Y. Humanin and the receptors for humanin[J]. Mol Neurobiol, 2010, 41(1): 22-28.
[7]
Oh YK,Bachar AR,Zacharias DG, et al. Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice[J]. Atherosclerosis, 2011, 219(1):65-73.
[8]
Adi R. Bachar,Lea Scheffer,Andreas S, et al. Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress [J]. Caridovascular Research, 2010, 88(2):360-366.
[9]
Kariya S,Takahashi N,Ooba NK, et al. Humanin inhibits cell death of serum-deprived PC12h cells [J]. Neuroreport, 2002, 13(6):903-907.
[10]
Tajima H,Niikura T,Hashimoto Y,et al. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer′s disease-related insults[J]. Neurosci Lett, 2002, 324(3):227-231.
[11]
Niikura T,Yamada M,Chiba T, et al. Characterization of V642I-AβPP-induced cytotoxicity in primary neurons [J]. J Neurosci Res, 2004, 77(1):54-62.
[12]
Hashimoto Y,Niikura T,Ito Y, et al. Detailed characterization of neuto-protection by a rescue factor humanin against various Alzheimer′s disease-relevant insults [J]. J Neurosci, 2001, 21(23):9235-9245.
[13]
Chiba T,Yamada M,Hashimoto Y, et al. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer′s disease-relevant insults in vitro and in vivo[J]. J Neurosci, 2005, 25(44):10252-10261.
[14]
Yamagishi Y,Hashimoto Y,Niikura T, et al. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer′s disease-relevant insults [J]. Peptide, 2003, 24(4):585-595.
[15]
Jung SS,Van Nostrand WE. Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity [J]. J Neurochem, 2003, 84(2):266-272.
[16]
Mamiya T,Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo[J]. Br J Pharmacol, 2001, 134(8):1597-1599.
[17]
Tajima H,Kawasumi M,Chiba T, et al. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice [J]. J Neurosci Res, 2005, 79(5): 714-723.
[18]
Yuan L,Han WN,Li SF, et al. [Gly14]-humanin protects against Aβ31-35-induced impairment of spatial learning and memory in rats[J]. Sheng Li Xue Bao, 2012, 64(6): 625-632.
[19]
Bachar AR,Scheffer L,Schroeder AS, et al. Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress [J]. Cardiovasc Res, 2010, 88(2):360-366.
[20]
Xu X,Chua CC,Gao J, et al. Humanin is a novel neuroprotective agent against stroke [J]. Stroke, 2006, 37(10):2613-2619.
[21]
Chiba T,Yamada M,Sasabe J, et al. Colivelin prolongs survival of an ALS model mouse [J]. Biochem Biophys Res Commun, 2006, 343(3):793-798.
[22]
Kuliawat R,Klein L,Gong Z, et al. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell [J]. FASEB J, 2013, 27(12):4890-4898.
[23]
Hoang PT,Park P,Cobb LJ, et al. The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonbese diabetic mice [J]. Metabolism 2010, 59(3):343-349.
[24]
Muzumdar RH,Huffman DM,Calvert JW, et al. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice[J]. Arterioscler Thromb Vasc Biol, 2010, 30(10):1940-1948.
[25]
Lue Y,Swerdloff R,Liu Q, et al. Opposing roles of insulin-like growth factor bingding protein 3 and humanmin in the regulation of testicular germ cell apoptosis [J]. Endocrinology, 2010, 151(1):350-357.
[26]
Zhao ST,Zhao L,Li JH, et al. Neuroprotective peptide humanin inhibits inflammatory response in astrocytes induced in lipopolysaccharide [J]. Neurochem Res, 2013, 38(3): 581-588.
[27]
Eriksson E,Wicksrtom M,Perup LS, et al. Protective role of humanin on bortezomibinduced bone growth impairment in anti-cancer treatment [J]. J Natl Cancer Inst, 2014, 106(3):djt459.
[28]
Cohen P. New role for the mitochondrial peptide humanin: Protective agent against chemotheraphy-induced side effects [J]. J Natl Cancer Inst, 2014, 106(3):dju006.
[29]
Matsuoka M,Hashimoto Y,Aiso S, et al. Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer′s disease and amyotrophic lateral sclerosis [J]. CNS Drug Rev, 2006, 12(2):113-122.
[30]
Hashimoto Y,Niikura T,Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide pectrum of familial Alzheimer′s disease genes and Abeta [J]. Proc Natl Acad Sci USA, 2001, 98(11):6336-6341.
[31]
Arakawa T,Hirano A,Shiraki K, et al. Advances in characterization of neuroprotective peptide, humanin [J]. Curr Med Chem, 2011, 18(36):5554-5563.
[32]
Tsukamoto E,Kadowaki H,Nishitoh H,Yamagishi Y, et al. The cytoplasmic domain of Alzheimer′s amyloid-protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH-terminal kinase-mediated neurotoxic signal via dimerization[J]. J Pharmacol Exp Ther, 2003, 306(3), 889-902.
[33]
Le Y,Gong W,Tiffany HL, et al. Amyloid - activates a G-protein-coupled chemoattractant receptor, FPR-like-1[J]. J Neurosci, 2001, 21(2), RC123.
[34]
Ying G,Iribarren P,Zhou Y,et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor[J]. J Immunol, 2004, 172(11): 7078-7085.
[35]
Hashimoto Y,Kurita M,Aiso S, et al. Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130[J]. Mol Biol Cell, 2009, 20(12):2864-2873.
[36]
Hashimoto Y,Kurita M,Matsuoka M. Identification of soluble WSX-1 not as a dominant-negative but as an alternative functional subunit of a receptor for an anti-Alzheimer′s disease rescue factor Humanin [J]. Biochem Biophys Res Commun, 2009, 389(1):95-99.
[37]
Yamada M,Chiba T,Sasabe J, et al. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer′s disease[J]. Neuropsychopharmacology, 2008, 33(8): 2020-2032.
[38]
Guo B,Zhai D,Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation [J]. Nature, 2003, 423(6938):456-461.
[39]
Hashimoto Y,Tsuji O,Niikura T, et al. Involvement of cJun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death[J]. J Neurochem, 2003, 84(4): 864-877.
[40]
Niikura T,Hashimoto Y,Tajima H, et al. A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer′s disease relevant insults [J]. Eur J Neurosci, 2003, 17(6):1150-1158.
[41]
Kariya S,Takahashi N,Hirano M, et al. Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes [J]. Mol Cell Biochem, 2003, 254(1/2): 83-89.
[42]
Yarchoan M,Xie SX,Kling MA, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias [J]. Brain, 2012, 135(12):3749-3756.
[43]
Chi NF,Chien LN,Ku HL, et al. Alzheimer disease and risk of stroke: A population-based cohort study [J]. Neurology, 2013, 80(8):705-711.
[44]
杨飞. 抗凋亡肽Humanin通过抑制高脂血症状态下血小板的高反应性缓解动脉粥样硬化的发展[D]. 苏州:苏州大学,2012:1-40.
[1] 郭翃江, 符雪彩, 朱妍妍, 严之红, 王丽娜, 纪红. 基于影响因素的老年阿尔茨海默病认知功能障碍预测模型构建及电子化认知康复训练的应用价值[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 156-161.
[2] 李敏, 刘云. 血清SAA、sNFL水平对老年阿尔茨海默病的预测价值分析[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(03): 157-161.
[3] 赵辛欣. 老年血管性痴呆患者外周血辅助性T细胞水平变化及临床意义[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(02): 90-95.
[4] 中国医师协会神经内科医师分会, 阿尔茨海默病药物临床试验写作组. 阿尔茨海默病药物临床试验中国专家共识[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(01): 9-20.
[5] 徐如祥, 杨超, 陈强, 张洪钿. 间充质干细胞治疗阿尔茨海默病的现状与展望[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(01): 1-5.
[6] 李嘉辰, 刘献增. 经颅磁刺激在阿尔茨海默病诊断及治疗中的研究进展[J]. 中华临床医师杂志(电子版), 2021, 15(04): 308-312.
[7] 许韵晨, 王憭瑶, 裴建. ApoE基因多态性与阿尔茨海默病中医证候的相关性探讨[J]. 中华针灸电子杂志, 2020, 09(04): 142-145.
[8] 刘倩, 李鑫, 刘欣, 苑金香. 铁死亡在阿尔茨海默病发病机制中的研究进展[J]. 中华诊断学电子杂志, 2022, 10(03): 211-215.
[9] 张梦阳, 王玥. 糖原合酶激酶-3β在阿尔茨海默病发病机制及治疗中作用的研究概况[J]. 中华诊断学电子杂志, 2019, 07(02): 98-102.
[10] 乔蕾, 孙寅轶, 曲忠森. tau蛋白和β-淀粉样蛋白在阿尔茨海默病病理过程中作用及自噬机制的研究概况[J]. 中华诊断学电子杂志, 2019, 07(02): 94-97.
[11] 胡华, 吴永华. 睡眠障碍与阿尔茨海默病[J]. 中华老年病研究电子杂志, 2020, 07(03): 41-47.
[12] 刘天姿, 王宝军. Toll样受体4在阿尔茨海默病中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 404-409.
[13] 夏禹, 刘寒, 朱瑞. 阿尔茨海默病及相关认知障碍疾病与早老素2基因相关性的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 290-293.
[14] 宋蕾, 吴寒, 侯双兴, 楼菁菁, 刘兴党. 关于阿尔茨海默病中视网膜和视神经及相关物质的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(05): 351-355.
[15] 周英奕, 时晶, 魏明清, 倪敬年, 李婷, 张立苹, 谭中建, 田金洲. 基于动脉自旋磁共振技术探讨阿尔茨海默病脑血流特点与认知功能的关系[J]. 中华脑血管病杂志(电子版), 2021, 15(05): 302-307.
阅读次数
全文


摘要